HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05136885 |
|
Recruitment Status :
Enrolling by invitation
First Posted : November 29, 2021
Last Update Posted : May 17, 2023
|
Sponsor:
Merit E. Cudkowicz, MD
Collaborator:
Seelos Therapeutics, Inc.
Information provided by (Responsible Party):
Merit E. Cudkowicz, MD, Massachusetts General Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | August 2023 |
| Estimated Study Completion Date : | September 2023 |